Navigation Links
Clues to Alzheimer's Spotted Earlier in Disease
Date:6/24/2009

Researchers found biomarkers in patients with only mild memory problems

WEDNESDAY, June 24 (HealthDay News) -- Biomarkers for Alzheimer's disease can be detected in the cerebrospinal fluid in the very early stages of the disease, a Swedish study suggests.

University of Gothenburg researchers analyzed cerebrospinal fluid (CSF) samples from 168 patients and found the typical pattern of biomarkers known as the "CSF AD profile" present in patients with mild memory problems, which is earlier than the illness could be detected by current tests.

"The earlier we can catch Alzheimer's disease, the more we can do for the patient," researcher Kaj Blennow said in a university news release. "The patients who had the typical changes in biomarker profile of the cerebrospinal fluid had a risk of deterioration that was 27 times higher than the control group. We could also see that all patients with mild cognitive impairment who deteriorated and developed Alzheimer's disease had these changes in the biomarker profile of their cerebrospinal fluid."

The study also found a relationship between the CFS AD profile and other typical signs of Alzheimer's, including the presence of the gene APOE e4 and deterioration of the area of the brain that controls memory.

Their discovery will have major significance "if the new type of pharmaceutical that can directly slow the progression of the disease proves to have a clinical effect," Blennow said. "It is important in this case to start treatment before the changes in the brain have become too severe," he added.

The study, which included patients from seven European countries, appears in the current issue of Lancet Neurology.

More information

The U.S. National Institute on Aging has more about the stages and symptoms of Alzheimer's disease.



-- Robert Preidt



SOURCE: University of Gothenburg, Sweden, news release, June 22, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Clues to Muscular Dystrophy Seen in Womb
2. Study gives clues to how adrenal cancer forms
3. Gene Gives Clues to Why Autism More Common in Boys
4. Singing brains offers epilepsy and schizophrenia clues
5. Genes Yield Clues to High Blood Pressure
6. Young Womens Breast Tissue Offers Clues to Cancer Risk
7. Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects
8. Zebrafish offer clues to treatments for motor neurone disease
9. Cat Food-Linked Illness Yields Clues to MS
10. Brain Cells Give New Clues to Alzheimers
11. Clues Found to Brain Mechanism Behind Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clues to Alzheimer's Spotted Earlier in Disease
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: